Udg Healthcare PLC (LON:UDG) Rating Reiterated by Liberum Capital

Udg Healthcare PLC (LON:UDG)‘s stock had its “buy” rating restated by research analysts at Liberum Capital in a research note issued on Wednesday. They currently have a GBX 930 ($12.05) price target on the stock. Liberum Capital’s price objective indicates a potential upside of 10.78% from the company’s previous close.

UDG has been the topic of a number of other research reports. Numis Securities Ltd reiterated a “hold” rating and set a GBX 730 ($9.46) target price on shares of Udg Healthcare PLC in a research report on Tuesday, May 23rd. Stifel Nicolaus increased their target price on Udg Healthcare PLC from GBX 620 ($8.03) to GBX 650 ($8.42) and gave the company a “hold” rating in a research report on Tuesday, April 4th. Berenberg Bank increased their target price on Udg Healthcare PLC from GBX 745 ($9.65) to GBX 800 ($10.36) and gave the company a “hold” rating in a research report on Friday, June 23rd. Jefferies Group LLC lowered Udg Healthcare PLC to a “hold” rating and increased their target price for the company from GBX 760 ($9.84) to GBX 785 ($10.17) in a research report on Wednesday, May 24th. Finally, Peel Hunt increased their target price on Udg Healthcare PLC from GBX 730 ($9.46) to GBX 830 ($10.75) and gave the company an “add” rating in a research report on Tuesday, May 23rd. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Udg Healthcare PLC currently has an average rating of “Hold” and an average price target of GBX 781.57 ($10.12).

Udg Healthcare PLC (UDG) opened at 841.00 on Wednesday. The stock’s market cap is GBX 2.08 billion. The stock has a 50 day moving average of GBX 814.44 and a 200 day moving average of GBX 722.73. Udg Healthcare PLC has a 12-month low of GBX 567.00 and a 12-month high of GBX 886.50.

The company also recently disclosed a dividend, which was paid on Tuesday, June 27th. Shareholders of record on Thursday, June 1st were issued a $0.04 dividend. The ex-dividend date was Thursday, June 1st. This represents a yield of 0.35%.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://transcriptdaily.com/2017/07/14/udg-healthcare-plc-lonudg-rating-reiterated-by-liberum-capital.html.

In other Udg Healthcare PLC news, insider Chris Corbin sold 100,000 shares of the firm’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of GBX 813 ($10.53), for a total value of £813,000 ($1,053,108.81). Also, insider Jez Moulding acquired 18,000 shares of the firm’s stock in a transaction on Wednesday, May 31st. The stock was purchased at an average price of GBX 808 ($10.47) per share, for a total transaction of £145,440 ($188,393.78).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply